Global Stem Cell Manufacturing Market to Reach $20.7 Billion by 2030
The global market for Stem Cell Manufacturing estimated at US$11.2 Billion in the year 2022, is projected to reach a revised size of US$20.7 Billion by 2030, growing at a CAGR of 8% over the analysis period 2022-2030. Culture Media, one of the segments analyzed in the report, is projected to record a 7.9% CAGR and reach US$8.4 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Consumables segment is readjusted to a revised 8.1% CAGR for the next 8-year period.The U.S. Market is Estimated at $3.3 Billion, While China is Forecast to Grow at 7.5% CAGR
The Stem Cell Manufacturing market in the U.S. is estimated at US$3.3 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$3.6 Billion by the year 2030 trailing a CAGR of 7.5% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.1% and 6.7% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 6.2% CAGR.Select Competitors (Total 33 Featured) -
- Anterogen
- Becton, Dickinson and Company
- Bio-Rad Laboratories
- Cellular Dynamics International
- Holostem Terapie Avanzate
- Lonza Group
- Medipost
- Merck Group
- Miltenyi Biotec
- Osiris Therapeutics
- Pharmicell
- Pluristem Therapeutics
- Stemcell Technologies
- Takara Bio Group
- Thermo Fisher Scientific
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIII. MARKET ANALYSISIV. COMPETITION
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Impact of Covid-19 and a Looming Global Recession
- Stem Cell Manufacturing - Global Key Competitors Percentage Market Share in 2022 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
4. GLOBAL MARKET PERSPECTIVE
- Table 1: World Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 2: World Historic Review for Stem Cell Manufacturing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- Table 3: World 18-Year Perspective for Stem Cell Manufacturing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2023 & 2030
- Table 4: World Recent Past, Current & Future Analysis for Culture Media by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 5: World Historic Review for Culture Media by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- Table 6: World 18-Year Perspective for Culture Media by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
- Table 7: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 8: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- Table 9: World 18-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
- Table 10: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 11: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- Table 12: World 18-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
- Table 13: World Recent Past, Current & Future Analysis for Stem Cell Lines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 14: World Historic Review for Stem Cell Lines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- Table 15: World 18-Year Perspective for Stem Cell Lines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
- Table 16: World Recent Past, Current & Future Analysis for Research-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 17: World Historic Review for Research-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- Table 18: World 18-Year Perspective for Research-based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
- Table 19: World Recent Past, Current & Future Analysis for Cell & Tissue Banking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 20: World Historic Review for Cell & Tissue Banking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- Table 21: World 18-Year Perspective for Cell & Tissue Banking by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
- Table 22: World Recent Past, Current & Future Analysis for Clinical-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 23: World Historic Review for Clinical-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- Table 24: World 18-Year Perspective for Clinical-based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
- Table 25: World Stem Cell Manufacturing Market Analysis of Annual Sales in US$ Million for Years 2012 through 2030
UNITED STATES
- Stem Cell Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
- Table 26: USA Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 27: USA Historic Review for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- Table 28: USA 18-Year Perspective for Stem Cell Manufacturing by Product - Percentage Breakdown of Value Sales for Culture Media, Consumables, Instruments and Stem Cell Lines for the Years 2012, 2023 & 2030
- Table 29: USA Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 30: USA Historic Review for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- Table 31: USA 18-Year Perspective for Stem Cell Manufacturing by Application - Percentage Breakdown of Value Sales for Research-based, Cell & Tissue Banking and Clinical-based for the Years 2012, 2023 & 2030
CANADA
- Table 32: Canada Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 33: Canada Historic Review for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- Table 34: Canada 18-Year Perspective for Stem Cell Manufacturing by Product - Percentage Breakdown of Value Sales for Culture Media, Consumables, Instruments and Stem Cell Lines for the Years 2012, 2023 & 2030
- Table 35: Canada Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 36: Canada Historic Review for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- Table 37: Canada 18-Year Perspective for Stem Cell Manufacturing by Application - Percentage Breakdown of Value Sales for Research-based, Cell & Tissue Banking and Clinical-based for the Years 2012, 2023 & 2030
JAPAN
- Stem Cell Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
- Table 38: Japan Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 39: Japan Historic Review for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- Table 40: Japan 18-Year Perspective for Stem Cell Manufacturing by Product - Percentage Breakdown of Value Sales for Culture Media, Consumables, Instruments and Stem Cell Lines for the Years 2012, 2023 & 2030
- Table 41: Japan Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 42: Japan Historic Review for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- Table 43: Japan 18-Year Perspective for Stem Cell Manufacturing by Application - Percentage Breakdown of Value Sales for Research-based, Cell & Tissue Banking and Clinical-based for the Years 2012, 2023 & 2030
CHINA
- Stem Cell Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
- Table 44: China Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 45: China Historic Review for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- Table 46: China 18-Year Perspective for Stem Cell Manufacturing by Product - Percentage Breakdown of Value Sales for Culture Media, Consumables, Instruments and Stem Cell Lines for the Years 2012, 2023 & 2030
- Table 47: China Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 48: China Historic Review for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- Table 49: China 18-Year Perspective for Stem Cell Manufacturing by Application - Percentage Breakdown of Value Sales for Research-based, Cell & Tissue Banking and Clinical-based for the Years 2012, 2023 & 2030
EUROPE
- Stem Cell Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
- Table 50: Europe Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 51: Europe Historic Review for Stem Cell Manufacturing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- Table 52: Europe 18-Year Perspective for Stem Cell Manufacturing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2023 & 2030
- Table 53: Europe Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 54: Europe Historic Review for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- Table 55: Europe 18-Year Perspective for Stem Cell Manufacturing by Product - Percentage Breakdown of Value Sales for Culture Media, Consumables, Instruments and Stem Cell Lines for the Years 2012, 2023 & 2030
- Table 56: Europe Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 57: Europe Historic Review for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- Table 58: Europe 18-Year Perspective for Stem Cell Manufacturing by Application - Percentage Breakdown of Value Sales for Research-based, Cell & Tissue Banking and Clinical-based for the Years 2012, 2023 & 2030
FRANCE
- Stem Cell Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
- Table 59: France Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 60: France Historic Review for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- Table 61: France 18-Year Perspective for Stem Cell Manufacturing by Product - Percentage Breakdown of Value Sales for Culture Media, Consumables, Instruments and Stem Cell Lines for the Years 2012, 2023 & 2030
- Table 62: France Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 63: France Historic Review for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- Table 64: France 18-Year Perspective for Stem Cell Manufacturing by Application - Percentage Breakdown of Value Sales for Research-based, Cell & Tissue Banking and Clinical-based for the Years 2012, 2023 & 2030
GERMANY
- Stem Cell Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
- Table 65: Germany Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 66: Germany Historic Review for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- Table 67: Germany 18-Year Perspective for Stem Cell Manufacturing by Product - Percentage Breakdown of Value Sales for Culture Media, Consumables, Instruments and Stem Cell Lines for the Years 2012, 2023 & 2030
- Table 68: Germany Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 69: Germany Historic Review for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- Table 70: Germany 18-Year Perspective for Stem Cell Manufacturing by Application - Percentage Breakdown of Value Sales for Research-based, Cell & Tissue Banking and Clinical-based for the Years 2012, 2023 & 2030
ITALY
- Table 71: Italy Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 72: Italy Historic Review for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- Table 73: Italy 18-Year Perspective for Stem Cell Manufacturing by Product - Percentage Breakdown of Value Sales for Culture Media, Consumables, Instruments and Stem Cell Lines for the Years 2012, 2023 & 2030
- Table 74: Italy Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 75: Italy Historic Review for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- Table 76: Italy 18-Year Perspective for Stem Cell Manufacturing by Application - Percentage Breakdown of Value Sales for Research-based, Cell & Tissue Banking and Clinical-based for the Years 2012, 2023 & 2030
UNITED KINGDOM
- Stem Cell Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
- Table 77: UK Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 78: UK Historic Review for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- Table 79: UK 18-Year Perspective for Stem Cell Manufacturing by Product - Percentage Breakdown of Value Sales for Culture Media, Consumables, Instruments and Stem Cell Lines for the Years 2012, 2023 & 2030
- Table 80: UK Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 81: UK Historic Review for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- Table 82: UK 18-Year Perspective for Stem Cell Manufacturing by Application - Percentage Breakdown of Value Sales for Research-based, Cell & Tissue Banking and Clinical-based for the Years 2012, 2023 & 2030
REST OF EUROPE
- Table 83: Rest of Europe Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 84: Rest of Europe Historic Review for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- Table 85: Rest of Europe 18-Year Perspective for Stem Cell Manufacturing by Product - Percentage Breakdown of Value Sales for Culture Media, Consumables, Instruments and Stem Cell Lines for the Years 2012, 2023 & 2030
- Table 86: Rest of Europe Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 87: Rest of Europe Historic Review for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- Table 88: Rest of Europe 18-Year Perspective for Stem Cell Manufacturing by Application - Percentage Breakdown of Value Sales for Research-based, Cell & Tissue Banking and Clinical-based for the Years 2012, 2023 & 2030
ASIA-PACIFIC
- Stem Cell Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
- Table 89: Asia-Pacific Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 90: Asia-Pacific Historic Review for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- Table 91: Asia-Pacific 18-Year Perspective for Stem Cell Manufacturing by Product - Percentage Breakdown of Value Sales for Culture Media, Consumables, Instruments and Stem Cell Lines for the Years 2012, 2023 & 2030
- Table 92: Asia-Pacific Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 93: Asia-Pacific Historic Review for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- Table 94: Asia-Pacific 18-Year Perspective for Stem Cell Manufacturing by Application - Percentage Breakdown of Value Sales for Research-based, Cell & Tissue Banking and Clinical-based for the Years 2012, 2023 & 2030
REST OF WORLD
- Table 95: Rest of World Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 96: Rest of World Historic Review for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- Table 97: Rest of World 18-Year Perspective for Stem Cell Manufacturing by Product - Percentage Breakdown of Value Sales for Culture Media, Consumables, Instruments and Stem Cell Lines for the Years 2012, 2023 & 2030
- Table 98: Rest of World Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 99: Rest of World Historic Review for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- Table 100: Rest of World 18-Year Perspective for Stem Cell Manufacturing by Application - Percentage Breakdown of Value Sales for Research-based, Cell & Tissue Banking and Clinical-based for the Years 2012, 2023 & 2030
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Anterogen
- Becton, Dickinson and Company
- Bio-Rad Laboratories
- Cellular Dynamics International
- Holostem Terapie Avanzate
- Lonza Group
- Medipost
- Merck Group
- Miltenyi Biotec
- Osiris Therapeutics
- Pharmicell
- Pluristem Therapeutics
- Stemcell Technologies
- Takara Bio Group
- Thermo Fisher Scientific
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 89 |
Published | April 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 11.2 Billion |
Forecasted Market Value ( USD | $ 20.7 Billion |
Compound Annual Growth Rate | 8.0% |
Regions Covered | Global |